Antiproliferative activity induced by the somatostatin analogue, TT-232, in human pancreatic cancer cells
- 1 July 2002
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 38 (11) , 1526-1534
- https://doi.org/10.1016/s0959-8049(02)00101-6
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology
This publication has 31 references indexed in Scilit:
- Role of Apoptosis in Duct Obstruction-Induced Pancreatic Involution in RatsPancreas, 1997
- Multiple intracellular effectors modulate physiological functions of the cloned somatostatin receptorsJournal of Molecular Endocrinology, 1996
- Induction of a negative autocrine loop by expression of sst2 somatostatin receptor in NIH 3T3 cells.Journal of Clinical Investigation, 1996
- Classification and nomenclature of somatostatin receptorsTrends in Pharmacological Sciences, 1995
- Somatostatin receptor expression in lung cancerEuropean Journal Of Cancer, 1994
- Cloning, Functional Expression and Pharmacological Characterization of a Fourth (hSSTR4) and a Fifth (hSSTR5) Human Somatostatin Receptor SubtypeBiochemical and Biophysical Research Communications, 1993
- Molecular Cloning and Sequencing of a Human Somatostatin Receptor, hSSTR4Biochemical and Biophysical Research Communications, 1993
- Molecular biology of somatostatin receptorsTrends in Neurosciences, 1993
- Stimulation of a membrane tyrosine phosphatase activity by somatostatin analogues in rat pancreatic acinar cellsEuropean Journal of Biochemistry, 1992
- Somatostatin analogue rc‐160 inhibits the growth of transplanted colon cancer in ratsInternational Journal of Cancer, 1991